Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 3/20 | 0.50 |
| ▸ | MMP12 | P39900 | 3/20 | 0.50 |
| ▸ | MMP1 | P03956 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.49 |
| ▸ | STS | P08842 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31203529 | 0.92 | NPC1 (0.49) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL828975 | 0.92 | NPC1 (0.49) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL828968 | 0.92 | NPC1 (0.49) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL10635329 | 0.88 | SERPINE1 (0.50) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL31069910 | 0.85 | MEN1 (0.57) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL8607117 | 0.85 | MEN1 (0.57) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL19668120 | 0.85 | MEN1 (0.57) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL29372521 | 0.85 | MEN1 (0.57) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL10707097 | 0.85 | MEN1 (0.57) | NPC1RAB9AMEN1KMT2AMMP9 | |
| SCHEMBL29302 | 0.85 | MEN1 (0.57) | NPC1RAB9AMEN1KMT2AMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | claimed |
| US-7595420-B2 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-09-29 | — | — | US | claimed |
| US-20060247461-A1 | Hydrogenation of benzene polycarboxylic acids or derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-11-02 | — | — | US | claimed |
| US-20260063999-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR POLYIMIDE CURED FILM USING SAME, AND POLYIMIDE CURED FILM | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-05 | — | — | US | disclosed |
| CN-120129876-A | Negative photosensitive resin composition, method for producing polyimide cured film using same, and polyimide cured film | 旭化成株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-118938601-A | Negative photosensitive resin composition and method for producing cured relief pattern | 旭化成株式会社 | 2024-11-12 | — | — | CN | disclosed |
| US-10017448-B2 | Process for hydrogenation of benzenepolycarboxylic acids and derivatives thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-20170291867-A1 | Improved Process for Hydrogenation of Benzenepolycarboxylic Acids and Derivatives Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-10-12 | — | — | US | disclosed |
| EP-3212605-A1 | IMPROVED PROCESS FOR HYDROGENATION OF BENZENEPOLYCARBOXYLIC ACIDS AND DERIVITIVES THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016066410-A1 | IMPROVED PROCESS FOR HYDROGENATION OF BENZENEPOLYCARBOXYLIC ACIDS AND DERIVITIVES THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-05-06 | — | — | WO | disclosed |
| US-9322955-B2 | Phase difference film, method for producing same, polarizing plate, and liquid crystal display device | Konica Minolta, Inc. (JP) | 2016-04-26 | — | — | US | disclosed |
| EP-0699543-B1 | Printing paper | SONY CORP (JP) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999032427-A1 | METHOD FOR HYDROGENATING BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF BY USING A CATALYST CONTAINING MACROPORES | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-01 | — | — | WO | disclosed |
| EP-0843718-A1 | BIODEGRADABLE FABRIC SOFTENER COMPOSITIONS WITH IMPROVED PERFUME LONGEVITY | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-27 | — | — | EP | disclosed |
| US-5668102-A | SOLID OR LIQUID COMPOSITION CONTAINING CATIONIC QUATERNARY AMMONIUM FABRIC SOFTENING COMPOUND, NONIONIC OR ANIONIC ESTER OF NON-ALLYLIC ALCOHOL PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-16 | — | — | US | disclosed |
| US-5635441-A | SHEET SUBSTRATE HAVING DYE RECEIVING LAYER OF CROSSLINKED COATING OBTAINED BY CURING MIXTURE OF BUTYRAL RESIN, VINYLPHENOLIC RESIN, POLYISOCYANATE; STORAGE STABLE IMAGES | SONY CORPORATION (JP) | 1997-06-03 | — | — | US | disclosed |
| WO-1997003174-A1 | BIODEGRADABLE FABRIC SOFTENER COMPOSITIONS WITH IMPROVED PERFUME LONGEVITY | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| US-5531910-A | DIESTERS WITH NON-ALLYLIC ALCOHOL PERFUMES, CATIONIC SURFACTANT | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-02 | — | — | US | disclosed |
| EP-0699543-A1 | Printing paper | SONY CORPORATION (JP) | 1996-03-06 | — | — | EP | disclosed |
| US-4259225-A | STORAGE STABILITY | DAINIPPON INK & CHEMICALS, INC. (JP) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260063999-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR POLYIMIDE CURED FILM USING SAME, AND POLYIMIDE CURED FILM | ARCN1, PBRM1, LCP1 | NPC1 4173/4885RAB9A 2025/4885MEN1 958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.